Xcout Intel
Atelerix
Atelerix is a biotechnology research company based in Newcastle upon Tyne, United Kingdom, that develops innovative cell and tissue preservation technologies using hydrogel technology for ambient temperature storage.
Subscribe to see Atelerix’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Atelerix at a glance
Atelerix is a healthtech company headquartered in United Kingdom, founded in 2017. It has raised at least $2.2M across the 3 funding rounds on record. Its most recent funding round, Pre-Seed, raised $932,856 in January 2025. Xcout tracks 7 named people at Atelerix, including Alastair Carrington (CEO).
Atelerix leadership
- Alastair CarringtonCEO
- Mick McLeanCEO
- Sunil ShahChair
- Steve SwiokloCo-Founder & CSO
- Andy EvansNon-Executive Director
- Catherine EltonNon-Executive Director
1 more named person on record for Atelerix, with roles, board committees and tenure — see the full roster →
Atelerix funding rounds
At least $2.2M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $932,856 | 3 named | |
| Seed | $700,000 | — | |
| Seed | $553,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Atelerix competitors
A few of Atelerix's closest competitors — see the full list of competitors and alternatives →
CryoStasis is a biotechnology company headquartered in Ottawa, Canada, specializing in the subzero unfrozen bio-preservation of cells, tissues, and organs.
AcroCyte Therapeutics, Inc. is a biotechnology company dedicated to overcoming common laboratory challenges through its proprietary R³CE rapid, reproducible, rare cell 3D expansion technology. Recognized with awards such as the Taiwan National Innovation Award, the company focuses on advancing biomedical research and cell-based applications.
Bit Bio is a UK biotechnology company that develops technologies for precisely programming human cells, including its opti-ox platform for producing consistent, scalable cell types. It serves biomedical researchers, drug developers, and regenerative-medicine and cell-therapy developers with engineered human cells and related tools.
Jurata Thin Film is a biotechnology firm specializing in innovative thin film technology designed to revolutionize biological sample storage and stabilization. The company maintains corporate operations and research facilities in Chapel Hill, North Carolina, and Houston, Texas.
RJH Biosciences develops transfection reagents and nucleic acid delivery systems for various human cells, cell lines, and preclinical animal models. The company serves the biomedical research and development sector by providing tailored products and contract research services for applications such as mRNA, DNA, siRNA, and CRISPR delivery.
Fluicell develops precision-engineered biological tissues and single-cell bioprinting technologies for regenerative medicine and drug screening. Using its proprietary platforms, including Nexocyte and Biopixlar, the company creates transplantable tissues to target diseases such as type 1 diabetes and provides advanced tools and screening models for pharmaceutical and academic partners.
Get Atelerix's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Atelerix in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access